Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
Gene And Cell Therapies In Rare Disorder - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Gene And Cell Therapies In Rare Disorder- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Gene And Cell Therapies In Rare Disorder, historical and forecasted epidemiology as well as the Gene And Cell Therapies In Rare Diso ... Read More
-
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022
“ PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in PD-1 and PD-L1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More
-
Alpha-1 Protease Inhibitor Deficiency - Epidemiology Forecast - 2032
DelveInsight's "" Alpha-1 Protease Inhibitor Deficiency - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Alpha-1 Protease Inhibitor Deficiency epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, a ... Read More
-
Gene Therapy for Ocular Rare Disease - Epidemiology Forecast - 2032
DelveInsight's "" Gene Therapy for Ocular Rare Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene Therapy for Ocular Rare Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Androgen Insensitivity Syndrome - Epidemiology Forecast - 2032
DelveInsight's "" Androgen Insensitivity Syndrome - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Androgen Insensitivity Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022
“ Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report provides detailed coverage of the pipeline landscape ... Read More
-
P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022
“ P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in P38 mitogen-activated protein (MAP) kinase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2022
“ Anti-CD28 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022
“ Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Hematopoietic progenitor kinase 1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022
“ Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Anti-CD279 (PD-1) Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2022
“ Anti-CD3 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
TrkC receptor antagonists - Pipeline Insight, 2022
“ TrkC receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in TrkC receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Nerve Repair and Regeneration- Market Insight, Competitive Landscape and Market Forecast- 2026
Nerve Repair and Regeneration- Market Insight, Competitive Landscape and Market Forecast- 2026 Nerve Repair and Regeneration Market By Surgery (Direct Neuropathy [Epineural Repair, Perineural Repair, Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, And Xenografts], Stem Cell Therapy ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2022
“ Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2022
“ T-cell Surface Glycoprotein CD4- Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in T-cell Surface Glycoprotein CD4 pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Graft Versus Host Disease (GvHD)- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Graft Versus Host Disease (GvHD), historical and forecasted epidemiology as well as the Graft Versus Host Disease (GvHD) market trends in th ... Read More
-
Liquid Biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026
Liquid Biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026 Liquid Biopsy in Cancer Diagnostics Market By Type (Product Type [Instruments And Reagents & Kits] And Services), By Sample Type (Blood, Urine, And Saliva), By Biomarker Type (Circulating Tumor Cell ... Read More
-
G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast - 2032
DelveInsight's "" G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted G Protein-Coupled Receptor (GPCR) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More
-
CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast - 2032
DelveInsight's "" CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CD19/CD20 Bi-specific CAR-T epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More
-
CD137 Agonist Antibody - Pipeline Insight, 2022
“ CD137 Agonist Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in CD137 Agonist Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022
“ Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landsca ... Read More
-
Immunoglobulin inhibitors - Pipeline Insight, 2022
“ Immunoglobulin inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Immunoglobulin inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Exosomes - Epidemiology Forecast - 2032
DelveInsight's "" Exosomes - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Exosomes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • T ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2022
“ Anti-CD52 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Trk (TrkB) receptor antagonists - Pipeline Insight, 2022
“ Trk (TrkB) receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Trk (TrkB) receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
Research Assistance
